Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension

Research output: Contribution to journalArticle

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{781a996107794f668761740d099ca494,
title = "Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension",
abstract = "BACKGROUND: The metabolic syndrome (MetS), predicting coronary heart disease (CHD), is a compound of risk factors including diabetes, obesity and hypertension. The relationship between the development of MetS, diabetes and CHD in patients with established hypertension is unclear. We hypothesized that patients with hypertension developing MetS are at increased risk of type II diabetes and CHD compared with patients who do not develop MetS. MATERIALS AND METHODS: We prospectively studied 284 patients (100 with existing/established MetS) with hypertension but without diabetes and CHD over 4 years. MetS and diabetes were diagnosed by the modified NCEP and ADA criteria, and CHD risk by the Framingham risk equation; all patients had annual fasting blood sampling. RESULTS: Over 4 years of follow up, 75 of the 184 patients (41%) initially free of MetS at baseline subsequently fulfilled the criteria for MetS. These patients (i.e. 'developing MetS') had higher baseline BMI, triglycerides and lower HDL cholesterol, with a higher calculated CHD risk (all P ",
author = "Hoong Lim and Gregory Lip and David Beevers and Andrew Blann",
year = "2005",
month = may,
day = "1",
doi = "10.1111/j.1365-2362.2005.01495.x",
language = "English",
volume = "35",
pages = "324--329",
journal = "European journal of clinical investigation",
issn = "0014-2972",
publisher = "Wiley",

}

RIS

TY - JOUR

T1 - Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension

AU - Lim, Hoong

AU - Lip, Gregory

AU - Beevers, David

AU - Blann, Andrew

PY - 2005/5/1

Y1 - 2005/5/1

N2 - BACKGROUND: The metabolic syndrome (MetS), predicting coronary heart disease (CHD), is a compound of risk factors including diabetes, obesity and hypertension. The relationship between the development of MetS, diabetes and CHD in patients with established hypertension is unclear. We hypothesized that patients with hypertension developing MetS are at increased risk of type II diabetes and CHD compared with patients who do not develop MetS. MATERIALS AND METHODS: We prospectively studied 284 patients (100 with existing/established MetS) with hypertension but without diabetes and CHD over 4 years. MetS and diabetes were diagnosed by the modified NCEP and ADA criteria, and CHD risk by the Framingham risk equation; all patients had annual fasting blood sampling. RESULTS: Over 4 years of follow up, 75 of the 184 patients (41%) initially free of MetS at baseline subsequently fulfilled the criteria for MetS. These patients (i.e. 'developing MetS') had higher baseline BMI, triglycerides and lower HDL cholesterol, with a higher calculated CHD risk (all P

AB - BACKGROUND: The metabolic syndrome (MetS), predicting coronary heart disease (CHD), is a compound of risk factors including diabetes, obesity and hypertension. The relationship between the development of MetS, diabetes and CHD in patients with established hypertension is unclear. We hypothesized that patients with hypertension developing MetS are at increased risk of type II diabetes and CHD compared with patients who do not develop MetS. MATERIALS AND METHODS: We prospectively studied 284 patients (100 with existing/established MetS) with hypertension but without diabetes and CHD over 4 years. MetS and diabetes were diagnosed by the modified NCEP and ADA criteria, and CHD risk by the Framingham risk equation; all patients had annual fasting blood sampling. RESULTS: Over 4 years of follow up, 75 of the 184 patients (41%) initially free of MetS at baseline subsequently fulfilled the criteria for MetS. These patients (i.e. 'developing MetS') had higher baseline BMI, triglycerides and lower HDL cholesterol, with a higher calculated CHD risk (all P

UR - http://www.scopus.com/inward/record.url?scp=18744369909&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2005.01495.x

DO - 10.1111/j.1365-2362.2005.01495.x

M3 - Article

C2 - 15860044

VL - 35

SP - 324

EP - 329

JO - European journal of clinical investigation

JF - European journal of clinical investigation

SN - 0014-2972

ER -